We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.

Torsten Hoof

GENERAL MANAGER, INTERNATIONAL

Joined Exact Sciences: 2019

Torsten Hoof has served as our General Manager, International since Exact Sciences’ acquisition of Genomic Health in November 2019. Mr. Hoof joined Genomic Health in September 2017 as Senior Vice President, International and was named Chief Commercial Officer, International in early 2019. Mr. Hoof previously served from 2015 to 2017 as the Vice President and Head of Oncology EMEA at Baxalta, where he built the company's oncology presence in Europe. From 2013 to 2014, Mr. Hoof was also the European General Manager for Endocyte, where he established its European organization designed to bring an innovative, precision medicine solution to patients with ovarian cancer. During his 10 years at Bristol-Myers Squibb, he led the global haemato-oncology franchise and was EMEA General Manager and Vice President for HIV and Primary Care. Earlier in his career with Roche, Torsten led the Tamiflu launch as a Global Business Leader and established Roche's German leadership position in Virology. Torsten also served as an Independent Director at HRA Pharma until its acquisition by Goldman Sachs and Astorg in 2016. Mr. Hoof holds master’s and doctoral degrees from the University of Hannover and is an alumnus of the Boehringer Ingelheim Fonds.